Chemed
359 hedge funds and large institutions have $4B invested in Chemed in 2018 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 109 increasing their positions, 138 reducing their positions, and 38 closing their positions.
508% more call options, than puts
Call options by funds: $5.98M | Put options by funds: $984K
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
21% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 38
2% more funds holding
Funds holding: 352 → 359 (+7)
0.17% less ownership
Funds ownership: 88.31% → 88.14% (-0.17%)
12% less capital invested
Capital invested by funds: $4.55B → $4B (-$550M)
21% less repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 138
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$21.8M |
| 2 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$13.8M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$13M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$12.4M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$11.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$24.6M |
| 2 |
Millennium Management
New York
|
-$18.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.6M |
| 4 |
D.E. Shaw & Co
New York
|
-$13M |
| 5 |
CWM
CIBC World Markets
New York
|
-$12.7M |
CHE Hedge Fund Activity: Q4 2018 in Review
359 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q4 2018, worth a combined $4B — down 12% from $4.55B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new CHE positions and 38 closed out — a net gain of 8 holders — while 109 added to existing stakes and 138 trimmed.
The largest buyer was Invesco, adding an estimated $21.8M. The largest seller was Goldman Sachs, cutting an estimated $24.6M.
- 359 institutional investors held Chemed (CHE) as of Q4 2018, up from 352 in Q3 2018.
- Funds reported $4B of Chemed stock for Q4 2018, down 12% quarter-over-quarter.
- 46 funds opened new Chemed positions in Q4 2018 and 38 closed out, a net change of +8 holders.
- The largest Chemed buyer in Q4 2018 was Invesco, an estimated $21.8M added.
- The largest Chemed seller in Q4 2018 was Goldman Sachs, an estimated $24.6M sold.
Based on aggregated 13F filings for Q4 2018.